evocatal Closes €3.5M Series B Funding
Summary
evocatal GmbH, a Düsseldorf, Germany-based enzyme specialist, closed a €3.5m Series B funding round.Backers included existing investors Roland Oetker, High-Tech Gründerfonds (HTGF), Sirius Seedfonds Düsseldorf (SSFD) and business angel Prof. Riesner and new investors Nrw.Bank and Lanxess.The company intends to use the funds to extend its technology platform as well as its product portfolio.Its biocatalysts are employed for the synthesis of pharmaceutical compounds and chemical intermediates, as well as in the production of consumer goods – for example in the manufacture and refinement of textiles, adhesives, detergents and cosmetics.FinSMEs 27/06/2013 Related News 06/07/2010: Evocatal Closes €2M in Growth Financing
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected